All In MedTech

FDA Clearance Tracker · P940016

H.E.L.P. SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Sep 19, 1997 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P940016
Device name
H.E.L.P. SYSTEM
Applicant location
Melsungen
Received
Jun 1, 1994
Decided
Sep 19, 1997
Decision
Approved
Supplements
20 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MMY

FDA's approval statement

As written in FDA's record.

Approval for the H.E.L.P. System. The device is a low density lipoprotein cholesterol (LDL-C) apheresis system, indicated for use in perofrming LDL-C apheresis to acutely remove LDL-C from the plasma of high risk patient populations for whom diet has been ineffective or not tolerated.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MMY. The earliest in FDA's data is P910018, decided Feb 21, 1996.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for B. Braun Avitum AG

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.